Skip to main content
Equibles

MESO · Mesoblast Ltd · Investor Relations

Track MESO — free

Use MESO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MESO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$14.50 +0.42 (+2.98%)
Rebalance outlook locked
Market Cap
$1.96B
Shares
129.85M
Volume · Oct 5 180.05K Avg daily vol (3M) 232.58K

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Date Headline
2026-10-01 Ceasing to be a substantial holder
2026-09-30 Becoming a substantial holder
2026-09-23 FDA Approves New Potency Assay for Commercial Ryoncil
2026-09-23 Ceasing to be a substantial holder
2026-08-26 MSB Annual Financial Results and Operational Update
2026-08-26 Annual Financial Results Presentation
2026-08-26 Preliminary Final Report including Appendix 4E
2026-08-24 Appendix 3Y - Philip Krause
2026-08-24 Notification regarding unquoted securities - MSB
2026-08-24 Mesoblast 2026 Full Year Financial Results Webcast
2026-08-17 Major Milestone Treatment Completed in P3 Trial for CLBP
2026-08-13 Becoming a substantial holder
2026-08-07 Ceasing to be a substantial holder
2026-08-05 Becoming a substantial holder
2026-08-03 Ceasing to be a substantial holder
2026-07-31 Becoming a substantial holder
2026-07-30 Quarterly Activities/Appendix 4C Cash Flow Report
2026-07-24 Ceasing to be a substantial holder
2026-07-21 Ceasing to be a substantial holder
2026-07-20 Mesoblast CEO Makes Investment to Increase Share Ownership
2026-07-20 Appendix 3Y - Silviu Itescu
2026-07-20 Notification regarding unquoted securities - MSB
2026-07-20 Application for quotation of securities - MSB
2026-07-14 Notification of cessation of securities - MSB

Past events

Date Event Type
2026-06-30 Financial Results and Operational Update for the Period Ended June 30, 2026 Event
2026-04-08 Mesoblast R&D Day Event
2026-02-27 Financial Results and Operational Update for the Period Ended December 31, 2025 Event
2025-12-31 Financial Results and Operational Update for the Period Ended December 31, 2025 Event
2023-05-26 Operational Highlights and Financial Results for the Period Ended March 31, 2023 Event
2023-02-28 Operational Highlights and Financial Results for the Period Ended December 31, 2022 Event
2022-02-24 Operational Highlights and Financial Results for the Period Ended December 31, 2021 Event
2021-08-30 Mesoblast 2021 Full Year Financial Results Results publication
2021-06-02 Financial Results for the period ended March 31, 2021 Event
2020-12-14 Mesoblast Company Update Event
2020-11-19 Financial Results and Operational Highlights for First Quarter Ended September 30, 2020 Event
2020-10-02 Corporate Update Event

Source: https://investorsmedia.mesoblast.com/stock-information/stock-quote

Key facts CIK 1345099 CUSIP 590717401 Visit website Investor relations